Overview
- 70 inspections across 68 sites are on record.
- 97 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2013-05-22.
At a glance
Inspections
70
Sites
68
Observations
97
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Stanford Clinical Laboratory at Hillview | 22 May 2013 | Biologics | |
| Stanford Healthcare ValleyCare | 15 May 2013 | Biologics | |
| Bruce A. Buckingham, M.D. | 23 Apr 2013 | Medical Devices & Rad Health | View 483 → |
| Berkeley Advanced Biomaterials, Inc. | 12 Apr 2013 | Biologics | |
| Titan Pharmaceuticals Inc | 1 Mar 2013 | Human Drugs |
Sites inspected
Stanford Clinical Laboratory at HillviewPalo Alto, United States1 insp.
Stanford Healthcare ValleyCarePleasanton, United States1 insp.
Bruce A. Buckingham, M.D.Palo Alto, United States1 insp.
Berkeley Advanced Biomaterials, Inc.Berkeley, United States1 insp.
Titan Pharmaceuticals IncSouth San Francisco, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Jennifer H Rhyu2 shared
Virgilio F Pacio2 shared
Robert S Sweeton1 shared
Joey V Quitania1 shared
Yvette E Guillermo1 shared
Full investigator report
Get the verbatim findings behind Mary E Wilkerson-Brinsko's 97 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site